[Diagnostics and Therapy of Neuropathic Pain]

Overview

Journal Anaesthesist

Specialty Anesthesiology

Date 2021 Oct 22

PMID 34676422

Citations 4

Authors

G Gossrau

R Sabatowski

Affiliations

Soon will be listed here.

Abstract

Neuropathic pain is pain caused by a lesion or disease of the somatosensory nervous system. Scientific studies have shown that neuropathic pain is the result of complex altered signalling processes in the peripheral and central nervous system. Current forms of treatment of neuropathic pain are causally oriented but also aim at symptomatic analgesia by pharmacological and nonpharmacological methods. Furthermore, psychological pain management techniques are used in a supportive role. This review summarizes the contemporary diagnostics of neuropathic pain using frequent diseases as examples and presents the evidence from randomized controlled trials on the treatment of neuropathic pain. Treatment guidelines for pharmacological management of neuropathic pain include evidence-based use of antidepressants, anticonvulsants, opioids, capsaicin and lidocaine.

Citing Articles

[Treatment of cancer-related pain-From pharmacotherapy to invasive procedures].

Hofbauer H, Wirz S, Steffen P, Kieselbach K, Kessler J Anaesthesiologie. 2024; 74(2):63-71.

PMID: 39668231 DOI: 10.1007/s00101-024-01488-0.

[Tumor-associated pain].

Wirz S, Kessler J, Hofbauer H Schmerz. 2024; 38(1):57-69.

PMID: 38206419 DOI: 10.1007/s00482-023-00782-x.

Effect of a high-fat and high-calorie food on the pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy subjects.

Wu Q, Zhu H, Song R, Zhang M, Li F, Zeng W Pharmacol Res Perspect. 2023; 11(3):e01102.

PMID: 37208866 PMC: 10199234. DOI: 10.1002/prp2.1102.

MRI Study of Cerebral Cortical Thickness in Patients with Herpes Zoster and Postherpetic Neuralgia.

Liu X, Gu L, Liu J, Hong S, Luo Q, Wu Y J Pain Res. 2022; 15:623-632.

PMID: 35250306 PMC: 8894103. DOI: 10.2147/JPR.S352105.

References

Attal N, Bouhassira D, Baron R . Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol. 2018; 17(5):456-466. DOI: 10.1016/S1474-4422(18)30071-1. View

Attal N, de Andrade D, Adam F, Ranoux D, Teixeira M, Galhardoni R . Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2016; 15(6):555-65. DOI: 10.1016/S1474-4422(16)00017-X. View

Baron R, Maier C, Attal N, Binder A, Bouhassira D, Cruccu G . Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain. 2016; 158(2):261-272. PMC: 5266425. DOI: 10.1097/j.pain.0000000000000753. View

Beloeil H, Sion B, Rousseau C, Albaladejo P, Raux M, Aubrun F . Early postoperative neuropathic pain assessed by the DN4 score predicts an increased risk of persistent postsurgical neuropathic pain. Eur J Anaesthesiol. 2017; 34(10):652-657. DOI: 10.1097/EJA.0000000000000634. View

Bendtsen L, Zakrzewska J, Heinskou T, Hodaie M, Leal P, Nurmikko T . Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol. 2020; 19(9):784-796. DOI: 10.1016/S1474-4422(20)30233-7. View

Bennett M . The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001; 92(1-2):147-57. DOI: 10.1016/s0304-3959(00)00482-6. View

Bhaskar A, Bell A, Boivin M, Briques W, Brown M, Clarke H . Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. J Cannabis Res. 2021; 3(1):22. PMC: 8252988. DOI: 10.1186/s42238-021-00073-1. View

Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J . Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005; 114(1-2):29-36. DOI: 10.1016/j.pain.2004.12.010. View

Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C . Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2007; 136(3):380-387. DOI: 10.1016/j.pain.2007.08.013. View

10.

Broggi G, Ferroli P, Franzini A, Servello D, Dones I . Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1999; 68(1):59-64. PMC: 1760596. DOI: 10.1136/jnnp.68.1.59. View

11.

Casser H, Huppe M, Kohlmann T, Korb J, Lindena G, Maier C . [German pain questionnaire and standardised documentation with the KEDOQ-Schmerz. A way for quality management in pain therapy]. Schmerz. 2012; 26(2):168-75. DOI: 10.1007/s00482-011-1142-0. View

12.

Chaparro L, Furlan A, Deshpande A, Mailis-Gagnon A, Atlas S, Turk D . Opioids compared to placebo or other treatments for chronic low-back pain. Cochrane Database Syst Rev. 2013; (8):CD004959. PMC: 11056234. DOI: 10.1002/14651858.CD004959.pub4. View

13.

Chen Q, Chen E, Qian X . A Narrative Review on Perioperative Pain Management Strategies in Enhanced Recovery Pathways-The Past, Present and Future. J Clin Med. 2021; 10(12). PMC: 8229260. DOI: 10.3390/jcm10122568. View

14.

Chen Y, Boden K, Schreiber K . The role of regional anaesthesia and multimodal analgesia in the prevention of chronic postoperative pain: a narrative review. Anaesthesia. 2021; 76 Suppl 1:8-17. PMC: 8369227. DOI: 10.1111/anae.15256. View

15.

Cruccu G, Truini A . A review of Neuropathic Pain: From Guidelines to Clinical Practice. Pain Ther. 2017; 6(Suppl 1):35-42. PMC: 5701894. DOI: 10.1007/s40122-017-0087-0. View

16.

de Greef B, Hoeijmakers J, Geerts M, Oakes M, Church T, Waxman S . Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial. Brain. 2019; 142(2):263-275. DOI: 10.1093/brain/awy329. View

17.

Demant D, Lund K, Vollert J, Maier C, Segerdahl M, Finnerup N . The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study. Pain. 2014; 155(11):2263-73. DOI: 10.1016/j.pain.2014.08.014. View

18.

Eccleston C, Fisher E, Thomas K, Hearn L, Derry S, Stannard C . Interventions for the reduction of prescribed opioid use in chronic non-cancer pain. Cochrane Database Syst Rev. 2017; 11:CD010323. PMC: 6486018. DOI: 10.1002/14651858.CD010323.pub3. View

19.

Dieleman J, Kerklaan J, Huygen F, Bouma P, Sturkenboom M . Incidence rates and treatment of neuropathic pain conditions in the general population. Pain. 2008; 137(3):681-688. DOI: 10.1016/j.pain.2008.03.002. View

20.

Farrar J, Young Jr J, Lamoreaux L, Werth J, Poole M . Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001; 94(2):149-158. DOI: 10.1016/S0304-3959(01)00349-9. View